Home > Insider Trading > Filing (0001628280-24-001036)

Filing Details

Accession Number:: 0001628280-24-001036
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-01-10 16:15:15
Reporting Period:: 2024-01-08

Accepted Time:: 2024-01-10 16:15:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1104506	Insmed Inc	INSM	Pharmaceutical Preparations (2834)	541972729

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1402051	William Lewis	700 Us Highway 202/206 Bridgewater NJ 08807	Chair And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-01-08	24,951	$20.49	398,489	No	4	M	Direct
Common Stock	Disposition	2024-01-08	24,951	$29.11	373,538	No	4	S	Direct
Common Stock	Acquisiton	2024-01-08	20,169	$20.49	393,707	No	4	M	Direct
Common Stock	Disposition	2024-01-08	20,169	$29.88	373,538	No	4	S	Direct
Common Stock	Disposition	2024-01-09	9,887	$28.72	363,651	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2024-01-08	45,120	$20.49	45,120	$20.49

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2024-01-10	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	233,924	Indirect	By ARTICLE 4 KATIE PROCTER DYNASTY TRUST
Common Stock	500	Indirect	By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A11/1/2020

Footnotes

This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
This is the weighted average sales price representing 24,951 shares sold at prices ranging from $28.71 to $29.68 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
This is the weighted average sales price representing 20,169 shares sold at prices ranging from $29.88 to $29.93 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
This is the weighted average sales price representing 9,887 shares sold at prices ranging from $28.62 to $28.84 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Stock options granted under the Company's 2013 Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. All options are currently exercisable and were scheduled to expire on January 10, 2024.